| Stage | SPXC | % of rev | ITT | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $715M | 100.00% | $1.5B | 100.00% | ITT ×2.06 |
| Gross profit | $280M | 39.12% | $510M | 34.63% | SPXC +4.5pp |
| Operating income | $115M | 16.14% | $180M | 12.24% | SPXC +3.9pp |
| Pre-tax income | $106M | 14.88% | $135M | 9.18% | SPXC +5.7pp |
| Net income | $82M | 11.46% | $87M | 5.87% | SPXC +5.6pp |
| Stage | SPXC | ITT | Gap · A − B |
|---|---|---|---|
| Revenue | $715M100.00% | $1.5B100.00% | ITT ×2.06 |
| Gross profit | 39.12%$280M | 34.63%$510M | SPXC +4.5pp |
| Operating income | 16.14%$115M | 12.24%$180M | SPXC +3.9pp |
| Pre-tax income | 14.88%$106M | 9.18%$135M | SPXC +5.7pp |
| Net income |
| 11.46%$82M |
| 5.87%$87M |
| SPXC +5.6pp |
No shared counterparties.